ZA200502829B - Novel substitutedÄ1,4ÜbezodioxinoÄ2,3-EÜisoindole derivatives, method for preparing same and pharmaceutical compositions containing same - Google Patents

Novel substitutedÄ1,4ÜbezodioxinoÄ2,3-EÜisoindole derivatives, method for preparing same and pharmaceutical compositions containing same Download PDF

Info

Publication number: ZA200502829B
Authority: ZA; South Africa
Prior art keywords: formula; compounds; compound; branched; linear
Prior art date: 2002-10-18

Application number

ZA200502829A

Other languages

English (en)

Inventor

Gerard Coudert

Nathalie Ayerbe

Franck Lepfire

Sylvain Routier

Daniel-Henri Caignard

Pierre Renard

John Hickman

Alain Pierre

Stephane Leonce

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-18

Filing date

2005-04-07

Publication date

2006-08-30

2005-04-07 Application filed by Servier Lab filed Critical Servier Lab

2006-08-30 Publication of ZA200502829B publication Critical patent/ZA200502829B/en

Links

238000000034 method Methods 0.000 title claims description 5
239000008194 pharmaceutical composition Substances 0.000 title claims description 4
150000001875 compounds Chemical class 0.000 claims description 129
125000000217 alkyl group Chemical group 0.000 claims description 40
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 30
239000002253 acid Substances 0.000 claims description 20
-1 cyano, hydroxy Chemical group 0.000 claims description 20
150000001204 N-oxides Chemical class 0.000 claims description 19
150000003839 salts Chemical class 0.000 claims description 19
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 18
125000003118 aryl group Chemical group 0.000 claims description 13
PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 claims description 8
125000003545 alkoxy group Chemical group 0.000 claims description 8
125000004432 carbon atom Chemical group C* 0.000 claims description 8
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 claims description 6
239000004342 Benzoyl peroxide Substances 0.000 claims description 4
OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 claims description 4
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 4
125000002947 alkylene group Chemical group 0.000 claims description 4
235000019400 benzoyl peroxide Nutrition 0.000 claims description 4
125000005843 halogen group Chemical group 0.000 claims description 4
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 claims description 4
229910052799 carbon Inorganic materials 0.000 claims description 3
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
238000002360 preparation method Methods 0.000 claims description 3
238000003786 synthesis reaction Methods 0.000 claims description 3
YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 claims description 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
206010028980 Neoplasm Diseases 0.000 claims description 2
125000006242 amine protecting group Chemical group 0.000 claims description 2
125000004104 aryloxy group Chemical group 0.000 claims description 2
UMFBSHOIEWBJOY-UHFFFAOYSA-N chembl1208806 Chemical compound C1=CC=C2OC3=C(C(N(C)C4=O)=O)C4=C(C=4C(=CC=CC=4)N4)C4=C3OC2=C1 UMFBSHOIEWBJOY-UHFFFAOYSA-N 0.000 claims description 2
FKGFNRQGWUGKCE-UHFFFAOYSA-N chembl1210190 Chemical compound C1=CC=C2OC3=C(C(N(C)C4=O)=O)C4=C(C=4C(=CC=C(F)C=4)N4)C4=C3OC2=C1 FKGFNRQGWUGKCE-UHFFFAOYSA-N 0.000 claims description 2
DEULHOMVRJFYFE-UHFFFAOYSA-N chembl1210191 Chemical compound C1=CC=C2OC3=C(C(N(C)C4=O)=O)C4=C(C=4C(=CC(F)=CC=4)N4)C4=C3OC2=C1 DEULHOMVRJFYFE-UHFFFAOYSA-N 0.000 claims description 2
GAZXQZAAZQGUAS-UHFFFAOYSA-N chembl1210258 Chemical compound C1=CC=C2OC3=C(C(N(CCN(C)C)C4=O)=O)C4=C(C=4C(=CC=C(F)C=4)N4)C4=C3OC2=C1 GAZXQZAAZQGUAS-UHFFFAOYSA-N 0.000 claims description 2
VZAJNAMCAWDCMR-UHFFFAOYSA-N chembl1210327 Chemical compound O1C2=CC=CC=C2OC2=C1C(C(=O)NC1=O)=C1C1=C2NC2=CC=C(O)C=C21 VZAJNAMCAWDCMR-UHFFFAOYSA-N 0.000 claims description 2
YGGJIDIWXQZWKV-UHFFFAOYSA-N chembl1210328 Chemical compound O1C2=CC=CC=C2OC2=C1C(C(=O)NC1=O)=C1C1=C2NC2=CC(O)=CC=C12 YGGJIDIWXQZWKV-UHFFFAOYSA-N 0.000 claims description 2
INLHJEQPNIOJHH-UHFFFAOYSA-N chembl1210421 Chemical compound C1=CC=C2OC3=C(C(N(CCN(C)C)C4=O)=O)C4=C(C=4C(=CC=C(O)C=4)N4)C4=C3OC2=C1 INLHJEQPNIOJHH-UHFFFAOYSA-N 0.000 claims description 2
JBCFWJIRALRSCK-UHFFFAOYSA-N chembl1210422 Chemical compound C1=CC=C2OC3=C(C(N(CCN(C)C)C4=O)=O)C4=C(C=4C(=CC(O)=CC=4)N4)C4=C3OC2=C1 JBCFWJIRALRSCK-UHFFFAOYSA-N 0.000 claims description 2
KWTSZCJMWHGPOS-UHFFFAOYSA-M chloro(trimethyl)stannane Chemical compound C[Sn](C)(C)Cl KWTSZCJMWHGPOS-UHFFFAOYSA-M 0.000 claims description 2
125000005046 dihydronaphthyl group Chemical group 0.000 claims description 2
229910052736 halogen Inorganic materials 0.000 claims description 2
150000002367 halogens Chemical class 0.000 claims description 2
229910052739 hydrogen Inorganic materials 0.000 claims description 2
239000001257 hydrogen Substances 0.000 claims description 2
125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 claims description 2
125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 claims description 2
125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 2
125000001624 naphthyl group Chemical group 0.000 claims description 2
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
125000004430 oxygen atom Chemical group O* 0.000 claims description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
UDJFFSGCRRMVFH-UHFFFAOYSA-N pyrido[2,3-d]pyrimidine Chemical compound N1=CN=CC2=CC=CN=C21 UDJFFSGCRRMVFH-UHFFFAOYSA-N 0.000 claims description 2
125000004076 pyridyl group Chemical group 0.000 claims description 2
235000009518 sodium iodide Nutrition 0.000 claims description 2
239000007858 starting material Substances 0.000 claims description 2
125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 claims description 2
125000004385 trihaloalkyl group Chemical group 0.000 claims description 2
238000006243 chemical reaction Methods 0.000 claims 3
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
239000004480 active ingredient Substances 0.000 claims 1
150000001412 amines Chemical group 0.000 claims 1
239000000010 aprotic solvent Substances 0.000 claims 1
239000000969 carrier Substances 0.000 claims 1
238000007796 conventional method Methods 0.000 claims 1
238000010511 deprotection reaction Methods 0.000 claims 1
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
239000012454 non-polar solvent Substances 0.000 claims 1
231100000252 nontoxic Toxicity 0.000 claims 1
230000003000 nontoxic effect Effects 0.000 claims 1
QJPQVXSHYBGQGM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 QJPQVXSHYBGQGM-UHFFFAOYSA-N 0.000 claims 1
239000000546 pharmaceutical excipient Substances 0.000 claims 1
238000000746 purification Methods 0.000 claims 1
238000000926 separation method Methods 0.000 claims 1
125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
230000000259 anti-tumor effect Effects 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
KNIDIOJLHQWUMR-UHFFFAOYSA-N 2h-[1,4]benzodioxino[2,3-e]isoindole Chemical class C1=CC2=CNC=C2C2=C1OC1=CC=CC=C1O2 KNIDIOJLHQWUMR-UHFFFAOYSA-N 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
HLPQGVMKCPPAAY-UHFFFAOYSA-N C1=NC=C2C3=CC=CC3=C(NC=C3)C3=C21 Chemical class C1=NC=C2C3=CC=CC3=C(NC=C3)C3=C21 HLPQGVMKCPPAAY-UHFFFAOYSA-N 0.000 description 1
LSPHULWDVZXLIL-UHFFFAOYSA-N Camphoric acid Natural products CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
206010011878 Deafness Diseases 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
230000001093 anti-cancer Effects 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
LHMRXAIRPKSGDE-UHFFFAOYSA-N benzo[a]anthracene-7,12-dione Chemical class C1=CC2=CC=CC=C2C2=C1C(=O)C1=CC=CC=C1C2=O LHMRXAIRPKSGDE-UHFFFAOYSA-N 0.000 description 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
LSPHULWDVZXLIL-QUBYGPBYSA-N camphoric acid Chemical compound CC1(C)[C@H](C(O)=O)CC[C@]1(C)C(O)=O LSPHULWDVZXLIL-QUBYGPBYSA-N 0.000 description 1
BGXSAMCEKHXLND-UHFFFAOYSA-N chembl1210257 Chemical compound C1=CC=C2OC3=C(C(N(CCN(C)C)C4=O)=O)C4=C(C=4C(=CC=CC=4)N4)C4=C3OC2=C1 BGXSAMCEKHXLND-UHFFFAOYSA-N 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
231100000895 deafness Toxicity 0.000 description 1
230000000694 effects Effects 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
208000016354 hearing loss disease Diseases 0.000 description 1
125000005842 heteroatom Chemical group 0.000 description 1
125000001041 indolyl group Chemical group 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
208000018883 loss of balance Diseases 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
230000002265 prevention Effects 0.000 description 1
QNMMYUBZGLXCCK-UHFFFAOYSA-N pyrrolo[3,2-a]carbazole Chemical class N1=C2C=CC=CC2=C2C1=C1C=CN=C1C=C2 QNMMYUBZGLXCCK-UHFFFAOYSA-N 0.000 description 1
229940107700 pyruvic acid Drugs 0.000 description 1
230000035807 sensation Effects 0.000 description 1
239000001117 sulphuric acid Substances 0.000 description 1
235000011149 sulphuric acid Nutrition 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

ZA200502829A 2002-10-18 2005-04-07 Novel substitutedÄ1,4ÜbezodioxinoÄ2,3-EÜisoindole derivatives, method for preparing same and pharmaceutical compositions containing same ZA200502829B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0212965A FR2845997B1 (fr)	2002-10-18	2002-10-18	Nouveaux derives de[1,4]benzodioxino[2,3-e]isoindole substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number	Publication Date
ZA200502829B true ZA200502829B (en)	2006-08-30

Family

ID=32050502

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200502829A ZA200502829B (en)	2002-10-18	2005-04-07	Novel substitutedÄ1,4ÜbezodioxinoÄ2,3-EÜisoindole derivatives, method for preparing same and pharmaceutical compositions containing same

Country Status (28)

Country	Link
US (1)	US7202255B2 (de)
EP (1)	EP1587810B1 (de)
JP (1)	JP2006507280A (de)
KR (1)	KR100695600B1 (de)
CN (1)	CN100412076C (de)
AR (1)	AR041654A1 (de)
AT (1)	ATE344800T1 (de)
AU (1)	AU2003301532A1 (de)
BR (1)	BR0314878A (de)
CA (1)	CA2502488A1 (de)
CY (1)	CY1105972T1 (de)
DE (1)	DE60309605T2 (de)
DK (1)	DK1587810T3 (de)
EA (1)	EA008498B1 (de)
ES (1)	ES2276160T3 (de)
FR (1)	FR2845997B1 (de)
GE (1)	GEP20074102B (de)
MA (1)	MA27340A1 (de)
MX (1)	MXPA05004113A (de)
MY (1)	MY136142A (de)
NO (1)	NO20052330L (de)
NZ (1)	NZ539195A (de)
PL (1)	PL375956A1 (de)
PT (1)	PT1587810E (de)
SI (1)	SI1587810T1 (de)
UA (1)	UA79997C2 (de)
WO (1)	WO2004037831A1 (de)
ZA (1)	ZA200502829B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8906928B2 (en) *	2009-03-31	2014-12-09	Arqule, Inc.	Substituted pyrazolo-pyrrolo-pyridine-dione compounds
CN103086947A (zh) *	2011-11-04	2013-05-08	赵庆春	具有抗血管生成活性的邻苯二甲酰亚胺类化合物及其用途
KR101614599B1 (ko) *	2014-04-09	2016-04-21	주식회사 두산	유기 화합물 및 이를 포함하는 유기 전계 발광 소자

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5705511A (en) *	1994-10-14	1998-01-06	Cephalon, Inc.	Fused pyrrolocarbazoles
AU4136197A (en) *	1996-09-09	1998-03-26	Kyowa Hakko Kogyo Co. Ltd.	Pyrrolocarbazole derivatives
FR2755691B1 (fr) *	1996-11-08	1998-12-04	Adir	Nouveaux derives 7,12-dioxa-benzo[a]anthraceniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

2002
- 2002-10-18 FR FR0212965A patent/FR2845997B1/fr not_active Expired - Fee Related
2003
- 2003-09-26 MY MYPI20033682A patent/MY136142A/en unknown
- 2003-10-17 CA CA002502488A patent/CA2502488A1/fr not_active Abandoned
- 2003-10-17 EA EA200500573A patent/EA008498B1/ru not_active IP Right Cessation
- 2003-10-17 AR ARP030103789A patent/AR041654A1/es not_active Application Discontinuation
- 2003-10-17 GE GEAP20038800A patent/GEP20074102B/en unknown
- 2003-10-17 DK DK03809363T patent/DK1587810T3/da active
- 2003-10-17 BR BR0314878-5A patent/BR0314878A/pt not_active IP Right Cessation
- 2003-10-17 PL PL03375956A patent/PL375956A1/xx not_active Application Discontinuation
- 2003-10-17 AT AT03809363T patent/ATE344800T1/de not_active IP Right Cessation
- 2003-10-17 DE DE60309605T patent/DE60309605T2/de not_active Expired - Fee Related
- 2003-10-17 EP EP03809363A patent/EP1587810B1/de not_active Expired - Lifetime
- 2003-10-17 AU AU2003301532A patent/AU2003301532A1/en not_active Abandoned
- 2003-10-17 KR KR1020057006695A patent/KR100695600B1/ko not_active Expired - Fee Related
- 2003-10-17 NZ NZ539195A patent/NZ539195A/en unknown
- 2003-10-17 US US10/531,393 patent/US7202255B2/en not_active Expired - Fee Related
- 2003-10-17 CN CNB2003801013475A patent/CN100412076C/zh not_active Expired - Fee Related
- 2003-10-17 JP JP2004546098A patent/JP2006507280A/ja active Pending
- 2003-10-17 WO PCT/FR2003/003069 patent/WO2004037831A1/fr not_active Ceased
- 2003-10-17 PT PT03809363T patent/PT1587810E/pt unknown
- 2003-10-17 ES ES03809363T patent/ES2276160T3/es not_active Expired - Lifetime
- 2003-10-17 SI SI200330583T patent/SI1587810T1/sl unknown
- 2003-10-17 MX MXPA05004113A patent/MXPA05004113A/es active IP Right Grant
- 2003-10-17 UA UAA200504634A patent/UA79997C2/uk unknown
2005
- 2005-03-30 MA MA28179A patent/MA27340A1/fr unknown
- 2005-04-07 ZA ZA200502829A patent/ZA200502829B/en unknown
- 2005-05-12 NO NO20052330A patent/NO20052330L/no not_active Application Discontinuation
2007
- 2007-01-31 CY CY20071100132T patent/CY1105972T1/el unknown

Also Published As

Publication number	Publication date
NZ539195A (en)	2007-05-31
WO2004037831A1 (fr)	2004-05-06
AR041654A1 (es)	2005-05-26
UA79997C2 (en)	2007-08-10
KR20050056251A (ko)	2005-06-14
SI1587810T1 (sl)	2007-02-28
ES2276160T3 (es)	2007-06-16
BR0314878A (pt)	2005-08-02
NO20052330D0 (no)	2005-05-12
AU2003301532A1 (en)	2004-05-13
MXPA05004113A (es)	2005-06-22
EA200500573A1 (ru)	2005-12-29
DK1587810T3 (da)	2007-03-05
GEP20074102B (en)	2007-05-10
PL375956A1 (en)	2005-12-12
PT1587810E (pt)	2007-02-28
US7202255B2 (en)	2007-04-10
CY1105972T1 (el)	2011-04-06
US20060040930A1 (en)	2006-02-23
EA008498B1 (ru)	2007-06-29
DE60309605T2 (de)	2007-09-27
CN100412076C (zh)	2008-08-20
EP1587810B1 (de)	2006-11-08
MA27340A1 (fr)	2005-05-02
CA2502488A1 (fr)	2004-05-06
MY136142A (en)	2008-08-29
DE60309605D1 (de)	2006-12-21
KR100695600B1 (ko)	2007-03-14
FR2845997B1 (fr)	2004-12-24
JP2006507280A (ja)	2006-03-02
FR2845997A1 (fr)	2004-04-23
ATE344800T1 (de)	2006-11-15
NO20052330L (no)	2005-05-12
CN1705672A (zh)	2005-12-07
EP1587810A1 (de)	2005-10-26

Publication	Publication Date	Title
AU687350B2 (en)	1998-02-26	Indolocarbazole imides and their use
FI935556A0 (fi)	1993-12-10	Imidazo(2,1-b)(3)bensazepinderivat och -kompositioner och foerfarande foer anvaendning av dem
TR200102136T2 (tr)	2001-11-21	Antikanser maddeleri olarak faydaı ikame-edilmiş bisiklik türevler.
FI92828B (fi)	1994-09-30	Menetelmä valmistaa terapeuttisesti arvokasta 5,11-dihydro-6H-dipyrido/3,2-b:2',3'-e/ /1,4/diatsepin-6-onia
Alvarez et al.	1999	Synthesis of 3-Aryl-and 3-Heteroaryl-7-azaindoles
CH682151A5 (de)	1993-07-30
CN116528871A (zh)	2023-08-01	一种吡唑并喹唑啉类化合物、其制备方法及应用
WO2003002563A1 (fr)	2003-01-09	Derives de pyrido-pyrido-pyrrolo pyrrolo-indole et pyrido-pyrrolo pyrrolo carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BRPI0717089A2 (pt)	2013-11-26	Derivados de quinolinona
US6548515B1 (en)	2003-04-15	Dihydrofuro[3,4-b]quinolin-1-one compounds
CN1278261A (zh)	2000-12-27	新型喜树碱衍生物
ZA200308629B (en)	2004-11-05	Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same.
JP3543196B2 (ja)	2004-07-14	６−エトキシ−２−［２’−（ジメチルアミノ）エチル］−１，２−ジヒドロ−３Ｈ−ジベンズ（ｄｅｈ）−イソキノリン−１，３−ジオン
WO2012091628A3 (ru)	2012-09-13	Замещенные гидрированные тиено-пирроло[3,2-с]пиридины, лиганды, фармацевтическая композиция и способ их применения
EA200001248A1 (ru)	2001-08-27	Новые линейные и циклические производные мочевины, способ их получения и их содержащие фармацевтические композиции
EP1587810B1 (de)	2006-11-08	Substituierte ¬1,4\|benzodioxin¬2,3-e\|isoindol-derivaten, ihr verfahren zur herstellung und ihre pharmazeutische zusammensetzungen
MXPA02001493A (es)	2002-07-02	Derivados fenantrolin-7-onas y sus aplicaciones terapeuticas..
IE64197B1 (en)	1995-07-12	Fused heteroalkylene quinolinamines a process and intermediates for their preparation and their use as medicaments
JP2006507269A (ja)	2006-03-02	ピロロ［３，４−ｃ］カルバゾールおよびピリド［２，３−ｂ］ピロロ［３，４−ｅ］インドール誘導体、その製造法、ならびにそれを含有する医薬組成物
CA2281244C (en)	2003-05-20	Process for preparing trovafloxacin acid salts
ZA200308628B (en)	2004-11-05	Tricyclic dihydroquinoline compounds, a process for their preparation and pharmaceutical compositions containing them.
IL98094A (en)	1996-01-31	Acylmethyl substituted pyrrolo (2,3-B) indoles and analogs a process for their preparation and their use as medicaments
AU4590302A (en)	2002-12-19	New indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them
KR910015583A (ko)	1991-09-30	락탐 유도체
TH54463A (th)	2002-12-17	4-(อะมิโนเมธิล)-พิเพอริดีน เบนแซมีด สำหรับรักษาโรคเกี่ยวกับกระเพาะอาหารและลำไส้